Building the infrastructure for the next era of regenerative medicine.
4th State Medical was created from the belief that regenerative medicine must evolve beyond isolated products. The next generation will require better devices, stronger scientific standards, disciplined regulatory development, clinical evidence, connected systems, and measurable outcomes.
To develop responsible, connected, and evidence-driven regenerative technologies that unite biology, devices, clinical collaboration, and data.
To help create a future in which regenerative medical technologies are more consistent, traceable, measurable, clinically understood, and responsibly scalable.
4th State Medical and 4th State Fusion.
Two complementary platforms serving distinct time horizons and audiences.
The medical, scientific, regulatory, clinical, and long-term technology platform. Home of the device platform, research library, regulatory roadmap, and investor portal.
The current commercial and aesthetics-facing platform for device sales, licensing, training, consumables, and near-term revenue generation.
A multidisciplinary team.
Company operations, strategy, and commercial development across the medical, device, and evidence platforms.
Advisors across regenerative biology, secretome science, extracellular vesicle biology, and translational research.
Physician leaders across wound care, dermatology, podiatry, plastic surgery, orthopedics, and sports medicine.
Institutional, industrial, and distribution partners. Announcements published as agreements are finalized.
A growing portfolio spanning device architecture, connected systems, consumables, and methods of use across regenerative delivery.
We are building a team focused on science, engineering, clinical development, and regulatory excellence. Open roles will be posted here.